In vitro TNF-α, IL-2 and IFN-γ production as markers of relapses in multiple sclerosis
- 1 November 1996
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 98 (4) , 286-290
- https://doi.org/10.1016/0303-8467(96)00041-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interleukin-2, soluble interleukin-2-receptor, neopterin,l-tryptophan and ?2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisZeitschrift für Neurologie, 1993
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992
- Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferonJournal of Neuroimmunology, 1991
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988
- Interferon-γ Enhances Biosynthesis of Pterins in Peripheral Blood Mononuclear Cells by Induction of GTP-Cyclohydrolase I ActivityJournal of Interferon Research, 1986
- Interferon induction, 2′-5′ oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal studyActa Neurologica Scandinavica, 1986
- CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSISThe Lancet, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983